vs
Side-by-side financial comparison of Aeluma, Inc. (ALMU) and Korro Bio, Inc. (KRRO). Click either name above to swap in a different company.
Korro Bio, Inc. is the larger business by last-quarter revenue ($1.3M vs $1.3M, roughly 1.0× Aeluma, Inc.). On growth, Aeluma, Inc. posted the faster year-over-year revenue change (-21.1% vs -43.1%). Aeluma, Inc. produced more free cash flow last quarter ($-282.0K vs $-79.1M).
Aeluma, Inc. is a U.S.-headquartered technology firm focused on the design, development, and production of high-performance optoelectronic components and semiconductor products. Its core offerings include photonic sensors and laser diodes, serving the LiDAR, 5G/6G communication, industrial sensing, and automotive markets across North America and the Asia-Pacific region.
Korro Bio, Inc. is a clinical-stage biotechnology company focused on developing innovative RNA editing therapies for rare and severe genetic diseases. It leverages its proprietary oligonucleotide platform to target disease-causing mutations, with core pipelines covering ophthalmology, respiratory and neuromuscular disorder segments, striving to address unmet medical needs for global patients.
ALMU vs KRRO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3M | $1.3M |
| Net Profit | $-1.9M | — |
| Gross Margin | 27.8% | — |
| Operating Margin | -163.6% | — |
| Net Margin | -145.7% | — |
| Revenue YoY | -21.1% | -43.1% |
| Net Profit YoY | 36.0% | -136.1% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3M | $1.3M | ||
| Q3 25 | $1.4M | $1.1M | ||
| Q2 25 | — | $1.5M | ||
| Q1 25 | — | $2.5M | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
| Q4 25 | $-1.9M | — | ||
| Q3 25 | $-1.5M | $-18.1M | ||
| Q2 25 | — | $-25.8M | ||
| Q1 25 | — | $-23.4M | ||
| Q3 24 | — | $-21.0M | ||
| Q2 24 | — | $-21.8M | ||
| Q1 24 | — | $-19.6M |
| Q4 25 | 27.8% | — | ||
| Q3 25 | 49.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -163.6% | — | ||
| Q3 25 | -116.1% | -1764.9% | ||
| Q2 25 | — | -1863.2% | ||
| Q1 25 | — | -981.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -145.7% | — | ||
| Q3 25 | -107.8% | -1657.0% | ||
| Q2 25 | — | -1765.1% | ||
| Q1 25 | — | -917.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.09 | $-1.92 | ||
| Q2 25 | — | $-2.74 | ||
| Q1 25 | — | $-2.49 | ||
| Q3 24 | — | $-2.26 | ||
| Q2 24 | — | $-2.43 | ||
| Q1 24 | — | $-2.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.6M | $75.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $40.8M | $51.4M |
| Total Assets | $42.6M | $113.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.6M | $75.2M | ||
| Q3 25 | $25.9M | $92.5M | ||
| Q2 25 | — | $96.4M | ||
| Q1 25 | — | $115.0M | ||
| Q3 24 | — | $137.0M | ||
| Q2 24 | — | $157.4M | ||
| Q1 24 | — | $138.8M |
| Q4 25 | $40.8M | $51.4M | ||
| Q3 25 | $40.9M | $99.0M | ||
| Q2 25 | — | $115.1M | ||
| Q1 25 | — | $139.0M | ||
| Q3 24 | — | $179.6M | ||
| Q2 24 | — | $198.1M | ||
| Q1 24 | — | $151.4M |
| Q4 25 | $42.6M | $113.5M | ||
| Q3 25 | $42.7M | $161.6M | ||
| Q2 25 | — | $180.4M | ||
| Q1 25 | — | $202.2M | ||
| Q3 24 | — | $243.5M | ||
| Q2 24 | — | $249.6M | ||
| Q1 24 | — | $198.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-251.0K | $-78.6M |
| Free Cash FlowOCF − Capex | $-282.0K | $-79.1M |
| FCF MarginFCF / Revenue | -22.2% | -6120.7% |
| Capex IntensityCapex / Revenue | 2.4% | 40.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-140.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-251.0K | $-78.6M | ||
| Q3 25 | $-815.0K | $-17.2M | ||
| Q2 25 | — | $-19.2M | ||
| Q1 25 | — | $-24.5M | ||
| Q3 24 | — | $-16.1M | ||
| Q2 24 | — | $-14.6M | ||
| Q1 24 | — | $-21.9M |
| Q4 25 | $-282.0K | $-79.1M | ||
| Q3 25 | $-1.0M | $-17.4M | ||
| Q2 25 | — | $-19.4M | ||
| Q1 25 | — | $-24.6M | ||
| Q3 24 | — | $-21.0M | ||
| Q2 24 | — | $-20.6M | ||
| Q1 24 | — | $-27.5M |
| Q4 25 | -22.2% | -6120.7% | ||
| Q3 25 | -74.0% | -1592.1% | ||
| Q2 25 | — | -1326.6% | ||
| Q1 25 | — | -963.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.4% | 40.1% | ||
| Q3 25 | 15.2% | 16.1% | ||
| Q2 25 | — | 9.6% | ||
| Q1 25 | — | 4.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
